Kbc Group Nv Novo Cure LTD Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Novo Cure LTD stock. As of the latest transaction made, Kbc Group Nv holds 3,369 shares of NVCR stock, worth $38,204. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,369

Previous 5,192 35.11%

Holding current value

$38,204

Previous $93,000 35.48%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$15.37 - $19.4 $28,019 - $35,366	-1,823 Reduced 35.11%	3,369 $60,000
Q1 2025 Apr 25, 2025	BUY	$17.82 - $30.19 $1,799 - $3,049	101 Added 1.98%	5,192 $93,000
Q4 2024 Jan 22, 2025	BUY	$14.54 - $33.41 $29,196 - $67,087	2,008 Added 65.13%	5,091 $152,000
Q4 2023 Feb 13, 2024	SELL	$11.13 - $15.78 $85,422 - $121,111	-7,675 Reduced 71.34%	3,083 $46,000
Q3 2023 Feb 15, 2024	SELL	$16.15 - $42.35 $126,890 - $332,743	-7,857 Reduced 73.03%	2,901 $47,000
Q2 2023 Feb 15, 2024	BUY	$40.29 - $82.51 $164,544 - $336,970	4,084 Added 61.19%	10,758 $446,000
Q2 2023 Jul 28, 2023	SELL	$40.29 - $82.51 $1.38 Million - $2.84 Million	-34,362 Reduced 76.16%	10,758 $446,000
Q1 2023 Feb 14, 2024	BUY	$56.44 - $118.81 $2.15 Million - $4.52 Million	38,063 Added 539.37%	45,120 $2.71 Million
Q1 2023 May 04, 2023	BUY	$56.44 - $118.81 $2.18 Million - $4.59 Million	38,628 Added 595.01%	45,120 $2.71 Million
Q4 2022 Feb 14, 2024	BUY	$63.98 - $85.37 $22,456 - $29,964	351 Added 5.23%	7,057 $517,000
Q3 2022 Feb 15, 2024	BUY	$67.99 - $89.57 $244,152 - $321,645	3,591 Added 116.48%	6,674 $507,000
Q2 2022 Feb 14, 2024	SELL	$56.6 - $89.9 $112,237 - $178,271	-1,983 Reduced 22.82%	6,706 $466,000
Q2 2022 Jul 26, 2022	SELL	$56.6 - $89.9 $124,350 - $197,510	-2,197 Reduced 25.28%	6,492 $451,000
Q4 2021 Feb 14, 2024	BUY	$75.08 - $121.99 $420,898 - $683,875	5,606 Added 181.84%	8,689 $652,000
Q4 2021 Feb 03, 2022	BUY	$75.08 - $121.99 $129,137 - $209,822	1,720 Added 24.68%	8,689 $652,000
Q4 2020 Feb 10, 2021	BUY	$112.16 - $174.14 $694,831 - $1.08 Million	6,195 Added 800.39%	6,969 $1.21 Million
Q2 2020 Aug 10, 2020	SELL	$57.2 - $74.41 $50,336 - $65,480	-880 Reduced 53.2%	774 $46,000
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $82,916 - $113,873	1,214 Added 275.91%	1,654 $139,000
Q3 2019 Nov 07, 2019	SELL	$61.86 - $97.8 $268,101 - $423,865	-4,334 Reduced 90.78%	440 $32,000
Q2 2019 Dec 03, 2019	BUY	$42.22 - $63.23 $201,558 - $301,860	4,774 New	4,774 $302,000
Q2 2019 Jul 30, 2019	SELL	$42.22 - $63.23 $201,558 - $301,860	-4,774 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$31.96 - $56.12 $152,577 - $267,916	4,774 New	4,774 $230,000
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $152,577 - $267,916	-4,774 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$28.72 - $52.63 $137,109 - $251,255	4,774 New	4,774 $160,000
Q4 2018 Jan 31, 2019	SELL	$28.72 - $52.63 $137,109 - $251,255	-4,774 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$32.0 - $52.4 $152,768 - $250,157	4,774 New	4,774 $259,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $152,768 - $250,157	-4,774 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$19.85 - $32.0 $94,763 - $152,768	4,774 New	4,774 $149,000
Q2 2018 Aug 03, 2018	SELL	$19.85 - $32.0 $117,988 - $190,208	-5,944 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$19.3 - $23.65 $114,719 - $140,575	5,944 New	5,944 $130,000
Q1 2018 May 09, 2018	SELL	$19.3 - $23.65 $91,173 - $111,722	-4,724 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$16.3 - $21.9 $77,001 - $103,455	4,724	4,724 $95,000

Others Institutions Holding NVCR

# of Institutions

276

Shares Held

75.7M

Call Options Held

920K

Put Options Held

130K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account